Year None202120202019201820172016 Date Latest Press Release November 11, 2020 Eiger Bio to Participate in November 2020 Investor Conferences November 5, 2020 Eiger BioPharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update November 2, 2020 Eiger Announces Abstracts Highlighting Peginterferon Lambda and Lonafarnib in Chronic Hepatitis Delta Virus (HDV) Infection Accepted for Presentation at The Liver Meeting Digital Experience™ 2020 October 15, 2020 Eiger BioPharmaceuticals Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-19 September 28, 2020 Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19 September 1, 2020 Eiger Bio to Participate in September 2020 Investor Conferences August 31, 2020 Eiger Announces Peginterferon Lambda - Lonafarnib Combination End of Treatment Results from Phase 2 LIFT HDV Study in Late Breaker Session at The Digital International Liver Congress™ 2020 August 6, 2020 Eiger BioPharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update August 3, 2020 Eiger BioPharmaceuticals to Participate in Upcoming August 2020 Investor Conferences May 29, 2020 Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
